These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22048228)

  • 1. Improving the decision-making process for nonprescription drugs: a framework for benefit-risk assessment.
    Brass EP; Lofstedt R; Renn O
    Clin Pharmacol Ther; 2011 Dec; 90(6):791-803. PubMed ID: 22048228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decision-analysis tool for benefit-risk assessment of nonprescription drugs.
    Brass EP; Lofstedt R; Renn O
    J Clin Pharmacol; 2013 May; 53(5):475-82. PubMed ID: 23381796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing the status of drugs from prescription to over-the-counter availability.
    Brass EP
    N Engl J Med; 2001 Sep; 345(11):810-6. PubMed ID: 11556302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of multiple end points in consumer research in support of switching drugs from prescription to over-the-counter status: the concept of end-point hierarchies.
    Brass EP; Shay LE; Leonard-Segal A
    Clin Pharmacol Ther; 2009 Apr; 85(4):369-74. PubMed ID: 19145230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new perspective on nonprescription statins: an opportunity for patient education and involvement.
    Fuster V
    Am J Cardiol; 2007 Sep; 100(5):907-10. PubMed ID: 17719344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caregivers' perspectives when evaluating nonprescription medication utilization in children.
    Eiland LS; Salazar ML; English TM
    Clin Pediatr (Phila); 2008 Jul; 47(6):578-87. PubMed ID: 18490663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk management and post-marketing surveillance of CNS drugs.
    Henningfield JE; Schuster CR
    Drug Alcohol Depend; 2009 Dec; 105 Suppl 1():S56-64. PubMed ID: 19767155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early benefit evaluation of drugs: procedure and bases for decision-making].
    Mueller EA; Kirch W
    Dtsch Med Wochenschr; 2012 Jan; 137(3):78-82. PubMed ID: 22241446
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of scientific evidence of risks and benefits in determining risk management policies for medications.
    Andrews E; Dombeck M
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):599-608. PubMed ID: 15362082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framework for use of toxicity screening tools in context-based decision-making.
    Doull J; Borzelleca JF; Becker R; Daston G; DeSesso J; Fan A; Fenner-Crisp P; Holsapple M; Holson J; Craig Llewellyn G; MacGregor J; Seed J; Walls I; Woo YT; Olin S
    Food Chem Toxicol; 2007 May; 45(5):759-96. PubMed ID: 17215066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Over-the-counter statins: benefit or harmful?].
    Guessous I; Rodondi N; Paccaud F
    Rev Med Suisse; 2005 Oct; 1(38):2447-8, 2451-2. PubMed ID: 16320536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonprescription availability of emergency contraception in the United States: current status, controversies, and impact on emergency medicine practice.
    Ranney ML; Gee EM; Merchant RC
    Ann Emerg Med; 2006 May; 47(5):461-71. PubMed ID: 16631987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General prescribing principles. Choosing a drug: 1.
    Lewis C; Allen D
    Nurs Stand; 2002 Dec 4-10; 17(12):2p. PubMed ID: 12518585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
    Wright C; Schnoll S; Bernstein D
    Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.
    Vamvakopoulos JE; Kountouri M; Marshall T; Greenfield SM
    Ann Pharmacother; 2008 Mar; 42(3):413-20. PubMed ID: 18303145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal use of nonprescription medications in college health centers.
    Caruso MM
    J Am Coll Health; 1995 Sep; 44(2):71-3. PubMed ID: 7593996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis.
    Garrison LP; Towse A; Bresnahan BW
    Health Aff (Millwood); 2007; 26(3):684-95. PubMed ID: 17485745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.